Atlas Trials

In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma

Clinical trial NCT05636540 · RECRUITING

Trial details

NCT number
NCT05636540
Sponsor
Heather Wachtel
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
PheochromocytomaParaganglioma
Start date
2023-07-01
Primary completion
2026-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.